Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Free Report) shares rose 6.1% during mid-day trading on Monday . The company traded as high as $23.01 and last traded at $23.00. Approximately 52,077 shares traded hands during trading, a decline of 77% from the average daily volume of 227,596 shares. The stock had previously closed at $21.68.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on ESTA shares. Stephens restated an “overweight” rating and issued a $89.00 price target on shares of Establishment Labs in a report on Friday, July 21st. JPMorgan Chase & Co. started coverage on Establishment Labs in a report on Thursday, August 31st. They issued an “overweight” rating and a $75.00 price target for the company. B. Riley decreased their price target on Establishment Labs from $95.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, November 9th. Finally, Mizuho decreased their price target on Establishment Labs from $80.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, November 8th. Six research analysts have rated the stock with a buy rating, According to MarketBeat, Establishment Labs has a consensus rating of “Buy” and a consensus target price of $74.67.
Establishment Labs Price Performance
Hedge Funds Weigh In On Establishment Labs
Several institutional investors and hedge funds have recently made changes to their positions in ESTA. GPS Wealth Strategies Group LLC purchased a new position in shares of Establishment Labs during the 2nd quarter valued at approximately $25,000. BNP Paribas Arbitrage SA raised its position in shares of Establishment Labs by 3,244.4% during the 1st quarter. BNP Paribas Arbitrage SA now owns 602 shares of the company’s stock valued at $41,000 after acquiring an additional 584 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in shares of Establishment Labs during the 3rd quarter valued at approximately $60,000. Lazard Asset Management LLC raised its position in shares of Establishment Labs by 104.5% during the 1st quarter. Lazard Asset Management LLC now owns 963 shares of the company’s stock valued at $64,000 after acquiring an additional 492 shares in the last quarter. Finally, Deutsche Bank AG acquired a new stake in shares of Establishment Labs during the 4th quarter valued at approximately $66,000. 78.56% of the stock is currently owned by hedge funds and other institutional investors.
Establishment Labs Company Profile
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
- Five stocks we like better than Establishment Labs
- What is a Mid Cap Stock? How to Invest
- Fisker Inc. price implosion; is it time to buy the dip?
- The Dividend Kings With Highest Yield
- The only 2 cannabis companies you need to own
- What is a Stock Market Index and How Do You Use Them?
- Is it time to buy EVOLV Technologies after post-earnings dip?
Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.